Nucro-Technics – Bacterial Reverse Mutation Test (Ames Assay

By: Nucro Technics  09-12-2011
Keywords: Reverse Mutation

Following OECD Guideline for the Testing of Chemicals – 471 Bacterial Reverse Mutation Test (1997), four S. typhimurium strains, TA98, TA100, TA1535, and TA1537, and one E. coli strain, WP2 uvrA, will be used. Dose range-finding test, a primary and a confirmatory mutagenicity test, will be conducted with and without the presence of rat liver S9 that is induced with Aroclor 1254. At least five exposure concentrations will be included in each experiment. Triplicate plates will be used at each dose level in the mutagenicity tests. A positive result is demonstrated by a dose-related increase or a reproducible increase in the number of revertants per plate. Usually, a clear positive result does not need to be confirmed. A negative result is always followed with the confirmatory test under slightly modified test conditions.

The experiments will start after the receipt of signed protocol and the test substance. A draft report will be ready for review within 4-6 weeks after the experiment start date. Archive of all documents will be for six years.

Keywords: Reverse Mutation

Contact Nucro Technics

Email - none provided

Print this page

Other products and services from Nucro Technics


Nucro-Technics – Mouse Lymphoma Assay

TK+/- cells are exposed to the test substance, both with and without metabolic activation, for a suitable period of time and subcultured to determine cytotoxicity and to allow phenotypic expression prior to mutant selection. In this assay, thymidine kinase proficient cells are exposed to the pyrimidine analogue trifluorothymidine , which causes the inhibition of cellular metabolism and halts further cell division.


Nucro-Technics – Genetic Toxicology Services

NUCRO-TECHNICS is capable of conducting testing of new Active Pharmaceutical Ingredients, biotechnology products, chemical, and other agents. The following array of test systems satisfies the test requirements of the FDA, OECD, ICH, EPA, EU, EMEA, ISO, USP and Health Canada. IN-VITRO DNA DAMAGE IN MAMMALIAN CELLS.


Nucro-Technics – Microbiology Services for the Pharmaceutical Industry

Environmental Audits, LAL, Particulate Matter Analyses, Antibiotic Analyses, Sterility Testing of drugs and devices, and bioburden determinations are some of the services that are offered. NUCRO-TECHNICS offers complete microbiological services for the Pharmaceutical, Biotechnology, Cosmetic, Medical Device, and Chemical Industries. The following is a brief listing of the type of Microbiology work that is done at Nucro-Technics.


Nucro-Technics – GLP Toxicology Services

All work is done to the appropriate standards, and subjects are maintained according to the requirements of the Animals for Research Act, the Guidelines of the Canadian Council on Animal Care, and the Association for Assessment and Accreditation of Laboratory Animal Care.


Nucro-Technics – Analytical Chemistry Testing

Each lab is equipped with state-of-the-art instrumentation to perform a wide range of chemical and instrumental analysis following procedures described in the USP/NF, BP, AOAC, EP, other compendia and clients’ procedures. NUCRO-TECHNICS provides a broad range of modern and classical Analytical Chemistry services to the Pharmaceutical, Biotechnology, Medical Device, and related industries.


Nucro-Technics: Contract Laboratory Services Summary

NUCRO-TECHNICS‘capabilities clearly distinguish us as a full service Pharmaceutical Contract Support Organization with qualifications and experience significantly different from those organizations that provide only testing services. Our employees have over 2000 years of combined practical experience and leadership in analyzing situations, developing strategies, creating new methods and procedures, and assisting clients with their products.


Nucro-Technics – Contract Bioanalytical Services

NUCRO-TECHNICS utilizes technologically advanced instrumentation to meet bioanalytical challenges and client demands using LC/MS/MS, HPLC and GC instrumentation to measure metabolite concentrations in biological matrices such as plasma, serum, CSF, urine, and tissue. The services provide bioanalytical support for non-clinical and clinical studies, including toxicokinetic studies, under both non-GLP and GLP conditions.